Global Brain Cancer Targeted Drug Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Description

According to our (Global Info Research) latest study, the global Brain Cancer Targeted Drug market size was valued at US$ 1529 million in 2024 and is forecast to a readjusted size of USD 2773 million by 2031 with a CAGR of 9.0% during review period.

A brain tumor is a mass or growth of abnormal cells in your brain. Many different types of brain tumors exist. 
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report is a detailed and comprehensive analysis for global Brain Cancer Targeted Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:
Global Brain Cancer Targeted Drug market size and forecasts, in consumption value ($ Million), 2020-2031
Global Brain Cancer Targeted Drug market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Brain Cancer Targeted Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Brain Cancer Targeted Drug market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Brain Cancer Targeted Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Brain Cancer Targeted Drug market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck & Co., Roche, Novartis, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Brain Cancer Targeted Drug market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Belzutifan (Welireg)
    Bevacizumab (Avastin)
    Everolimus (Afinitor)

Market segment by Application
    Hospital
    Retail Pharmacy
    Other

Market segment by players, this report covers
    Merck & Co.
    Roche
    Novartis

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Brain Cancer Targeted Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Brain Cancer Targeted Drug, with revenue, gross margin, and global market share of Brain Cancer Targeted Drug from 2020 to 2025.
Chapter 3, the Brain Cancer Targeted Drug competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Brain Cancer Targeted Drug market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Brain Cancer Targeted Drug.
Chapter 13, to describe Brain Cancer Targeted Drug research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Brain Cancer Targeted Drug by Type
        1.3.1 Overview: Global Brain Cancer Targeted Drug Market Size by Type: 2020 Versus 2024 Versus 2031
        1.3.2 Global Brain Cancer Targeted Drug Consumption Value Market Share by Type in 2024
        1.3.3 Belzutifan (Welireg)
        1.3.4 Bevacizumab (Avastin)
        1.3.5 Everolimus (Afinitor)
    1.4 Global Brain Cancer Targeted Drug Market by Application
        1.4.1 Overview: Global Brain Cancer Targeted Drug Market Size by Application: 2020 Versus 2024 Versus 2031
        1.4.2 Hospital
        1.4.3 Retail Pharmacy
        1.4.4 Other
    1.5 Global Brain Cancer Targeted Drug Market Size & Forecast
    1.6 Global Brain Cancer Targeted Drug Market Size and Forecast by Region
        1.6.1 Global Brain Cancer Targeted Drug Market Size by Region: 2020 VS 2024 VS 2031
        1.6.2 Global Brain Cancer Targeted Drug Market Size by Region, (2020-2031)
        1.6.3 North America Brain Cancer Targeted Drug Market Size and Prospect (2020-2031)
        1.6.4 Europe Brain Cancer Targeted Drug Market Size and Prospect (2020-2031)
        1.6.5 Asia-Pacific Brain Cancer Targeted Drug Market Size and Prospect (2020-2031)
        1.6.6 South America Brain Cancer Targeted Drug Market Size and Prospect (2020-2031)
        1.6.7 Middle East & Africa Brain Cancer Targeted Drug Market Size and Prospect (2020-2031)

2 Company Profiles
    2.1 Merck & Co.
        2.1.1 Merck & Co. Details
        2.1.2 Merck & Co. Major Business
        2.1.3 Merck & Co. Brain Cancer Targeted Drug Product and Solutions
        2.1.4 Merck & Co. Brain Cancer Targeted Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.1.5 Merck & Co. Recent Developments and Future Plans
    2.2 Roche
        2.2.1 Roche Details
        2.2.2 Roche Major Business
        2.2.3 Roche Brain Cancer Targeted Drug Product and Solutions
        2.2.4 Roche Brain Cancer Targeted Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.2.5 Roche Recent Developments and Future Plans
    2.3 Novartis
        2.3.1 Novartis Details
        2.3.2 Novartis Major Business
        2.3.3 Novartis Brain Cancer Targeted Drug Product and Solutions
        2.3.4 Novartis Brain Cancer Targeted Drug Revenue, Gross Margin and Market Share (2020-2025)
        2.3.5 Novartis Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Brain Cancer Targeted Drug Revenue and Share by Players (2020-2025)
    3.2 Market Share Analysis (2024)
        3.2.1 Market Share of Brain Cancer Targeted Drug by Company Revenue
        3.2.2 Top 3 Brain Cancer Targeted Drug Players Market Share in 2024
        3.2.3 Top 6 Brain Cancer Targeted Drug Players Market Share in 2024
    3.3 Brain Cancer Targeted Drug Market: Overall Company Footprint Analysis
        3.3.1 Brain Cancer Targeted Drug Market: Region Footprint
        3.3.2 Brain Cancer Targeted Drug Market: Company Product Type Footprint
        3.3.3 Brain Cancer Targeted Drug Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Brain Cancer Targeted Drug Consumption Value and Market Share by Type (2020-2025)
    4.2 Global Brain Cancer Targeted Drug Market Forecast by Type (2026-2031)

5 Market Size Segment by Application
    5.1 Global Brain Cancer Targeted Drug Consumption Value Market Share by Application (2020-2025)
    5.2 Global Brain Cancer Targeted Drug Market Forecast by Application (2026-2031)

6 North America
    6.1 North America Brain Cancer Targeted Drug Consumption Value by Type (2020-2031)
    6.2 North America Brain Cancer Targeted Drug Market Size by Application (2020-2031)
    6.3 North America Brain Cancer Targeted Drug Market Size by Country
        6.3.1 North America Brain Cancer Targeted Drug Consumption Value by Country (2020-2031)
        6.3.2 United States Brain Cancer Targeted Drug Market Size and Forecast (2020-2031)
        6.3.3 Canada Brain Cancer Targeted Drug Market Size and Forecast (2020-2031)
        6.3.4 Mexico Brain Cancer Targeted Drug Market Size and Forecast (2020-2031)

7 Europe
    7.1 Europe Brain Cancer Targeted Drug Consumption Value by Type (2020-2031)
    7.2 Europe Brain Cancer Targeted Drug Consumption Value by Application (2020-2031)
    7.3 Europe Brain Cancer Targeted Drug Market Size by Country
        7.3.1 Europe Brain Cancer Targeted Drug Consumption Value by Country (2020-2031)
        7.3.2 Germany Brain Cancer Targeted Drug Market Size and Forecast (2020-2031)
        7.3.3 France Brain Cancer Targeted Drug Market Size and Forecast (2020-2031)
        7.3.4 United Kingdom Brain Cancer Targeted Drug Market Size and Forecast (2020-2031)
        7.3.5 Russia Brain Cancer Targeted Drug Market Size and Forecast (2020-2031)
        7.3.6 Italy Brain Cancer Targeted Drug Market Size and Forecast (2020-2031)

8 Asia-Pacific
    8.1 Asia-Pacific Brain Cancer Targeted Drug Consumption Value by Type (2020-2031)
    8.2 Asia-Pacific Brain Cancer Targeted Drug Consumption Value by Application (2020-2031)
    8.3 Asia-Pacific Brain Cancer Targeted Drug Market Size by Region
        8.3.1 Asia-Pacific Brain Cancer Targeted Drug Consumption Value by Region (2020-2031)
        8.3.2 China Brain Cancer Targeted Drug Market Size and Forecast (2020-2031)
        8.3.3 Japan Brain Cancer Targeted Drug Market Size and Forecast (2020-2031)
        8.3.4 South Korea Brain Cancer Targeted Drug Market Size and Forecast (2020-2031)
        8.3.5 India Brain Cancer Targeted Drug Market Size and Forecast (2020-2031)
        8.3.6 Southeast Asia Brain Cancer Targeted Drug Market Size and Forecast (2020-2031)
        8.3.7 Australia Brain Cancer Targeted Drug Market Size and Forecast (2020-2031)

9 South America
    9.1 South America Brain Cancer Targeted Drug Consumption Value by Type (2020-2031)
    9.2 South America Brain Cancer Targeted Drug Consumption Value by Application (2020-2031)
    9.3 South America Brain Cancer Targeted Drug Market Size by Country
        9.3.1 South America Brain Cancer Targeted Drug Consumption Value by Country (2020-2031)
        9.3.2 Brazil Brain Cancer Targeted Drug Market Size and Forecast (2020-2031)
        9.3.3 Argentina Brain Cancer Targeted Drug Market Size and Forecast (2020-2031)

10 Middle East & Africa
    10.1 Middle East & Africa Brain Cancer Targeted Drug Consumption Value by Type (2020-2031)
    10.2 Middle East & Africa Brain Cancer Targeted Drug Consumption Value by Application (2020-2031)
    10.3 Middle East & Africa Brain Cancer Targeted Drug Market Size by Country
        10.3.1 Middle East & Africa Brain Cancer Targeted Drug Consumption Value by Country (2020-2031)
        10.3.2 Turkey Brain Cancer Targeted Drug Market Size and Forecast (2020-2031)
        10.3.3 Saudi Arabia Brain Cancer Targeted Drug Market Size and Forecast (2020-2031)
        10.3.4 UAE Brain Cancer Targeted Drug Market Size and Forecast (2020-2031)

11 Market Dynamics
    11.1 Brain Cancer Targeted Drug Market Drivers
    11.2 Brain Cancer Targeted Drug Market Restraints
    11.3 Brain Cancer Targeted Drug Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Brain Cancer Targeted Drug Industry Chain
    12.2 Brain Cancer Targeted Drug Upstream Analysis
    12.3 Brain Cancer Targeted Drug Midstream Analysis
    12.4 Brain Cancer Targeted Drug Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Brain Cancer Targeted Drug Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Table 2. Global Brain Cancer Targeted Drug Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Table 3. Global Brain Cancer Targeted Drug Consumption Value by Region (2020-2025) & (USD Million)
 Table 4. Global Brain Cancer Targeted Drug Consumption Value by Region (2026-2031) & (USD Million)
 Table 5. Merck & Co. Company Information, Head Office, and Major Competitors
 Table 6. Merck & Co. Major Business
 Table 7. Merck & Co. Brain Cancer Targeted Drug Product and Solutions
 Table 8. Merck & Co. Brain Cancer Targeted Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 9. Merck & Co. Recent Developments and Future Plans
 Table 10. Roche Company Information, Head Office, and Major Competitors
 Table 11. Roche Major Business
 Table 12. Roche Brain Cancer Targeted Drug Product and Solutions
 Table 13. Roche Brain Cancer Targeted Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 14. Roche Recent Developments and Future Plans
 Table 15. Novartis Company Information, Head Office, and Major Competitors
 Table 16. Novartis Major Business
 Table 17. Novartis Brain Cancer Targeted Drug Product and Solutions
 Table 18. Novartis Brain Cancer Targeted Drug Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 19. Global Brain Cancer Targeted Drug Revenue (USD Million) by Players (2020-2025)
 Table 20. Global Brain Cancer Targeted Drug Revenue Share by Players (2020-2025)
 Table 21. Breakdown of Brain Cancer Targeted Drug by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 22. Market Position of Players in Brain Cancer Targeted Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
 Table 23. Head Office of Key Brain Cancer Targeted Drug Players
 Table 24. Brain Cancer Targeted Drug Market: Company Product Type Footprint
 Table 25. Brain Cancer Targeted Drug Market: Company Product Application Footprint
 Table 26. Brain Cancer Targeted Drug New Market Entrants and Barriers to Market Entry
 Table 27. Brain Cancer Targeted Drug Mergers, Acquisition, Agreements, and Collaborations
 Table 28. Global Brain Cancer Targeted Drug Consumption Value (USD Million) by Type (2020-2025)
 Table 29. Global Brain Cancer Targeted Drug Consumption Value Share by Type (2020-2025)
 Table 30. Global Brain Cancer Targeted Drug Consumption Value Forecast by Type (2026-2031)
 Table 31. Global Brain Cancer Targeted Drug Consumption Value by Application (2020-2025)
 Table 32. Global Brain Cancer Targeted Drug Consumption Value Forecast by Application (2026-2031)
 Table 33. North America Brain Cancer Targeted Drug Consumption Value by Type (2020-2025) & (USD Million)
 Table 34. North America Brain Cancer Targeted Drug Consumption Value by Type (2026-2031) & (USD Million)
 Table 35. North America Brain Cancer Targeted Drug Consumption Value by Application (2020-2025) & (USD Million)
 Table 36. North America Brain Cancer Targeted Drug Consumption Value by Application (2026-2031) & (USD Million)
 Table 37. North America Brain Cancer Targeted Drug Consumption Value by Country (2020-2025) & (USD Million)
 Table 38. North America Brain Cancer Targeted Drug Consumption Value by Country (2026-2031) & (USD Million)
 Table 39. Europe Brain Cancer Targeted Drug Consumption Value by Type (2020-2025) & (USD Million)
 Table 40. Europe Brain Cancer Targeted Drug Consumption Value by Type (2026-2031) & (USD Million)
 Table 41. Europe Brain Cancer Targeted Drug Consumption Value by Application (2020-2025) & (USD Million)
 Table 42. Europe Brain Cancer Targeted Drug Consumption Value by Application (2026-2031) & (USD Million)
 Table 43. Europe Brain Cancer Targeted Drug Consumption Value by Country (2020-2025) & (USD Million)
 Table 44. Europe Brain Cancer Targeted Drug Consumption Value by Country (2026-2031) & (USD Million)
 Table 45. Asia-Pacific Brain Cancer Targeted Drug Consumption Value by Type (2020-2025) & (USD Million)
 Table 46. Asia-Pacific Brain Cancer Targeted Drug Consumption Value by Type (2026-2031) & (USD Million)
 Table 47. Asia-Pacific Brain Cancer Targeted Drug Consumption Value by Application (2020-2025) & (USD Million)
 Table 48. Asia-Pacific Brain Cancer Targeted Drug Consumption Value by Application (2026-2031) & (USD Million)
 Table 49. Asia-Pacific Brain Cancer Targeted Drug Consumption Value by Region (2020-2025) & (USD Million)
 Table 50. Asia-Pacific Brain Cancer Targeted Drug Consumption Value by Region (2026-2031) & (USD Million)
 Table 51. South America Brain Cancer Targeted Drug Consumption Value by Type (2020-2025) & (USD Million)
 Table 52. South America Brain Cancer Targeted Drug Consumption Value by Type (2026-2031) & (USD Million)
 Table 53. South America Brain Cancer Targeted Drug Consumption Value by Application (2020-2025) & (USD Million)
 Table 54. South America Brain Cancer Targeted Drug Consumption Value by Application (2026-2031) & (USD Million)
 Table 55. South America Brain Cancer Targeted Drug Consumption Value by Country (2020-2025) & (USD Million)
 Table 56. South America Brain Cancer Targeted Drug Consumption Value by Country (2026-2031) & (USD Million)
 Table 57. Middle East & Africa Brain Cancer Targeted Drug Consumption Value by Type (2020-2025) & (USD Million)
 Table 58. Middle East & Africa Brain Cancer Targeted Drug Consumption Value by Type (2026-2031) & (USD Million)
 Table 59. Middle East & Africa Brain Cancer Targeted Drug Consumption Value by Application (2020-2025) & (USD Million)
 Table 60. Middle East & Africa Brain Cancer Targeted Drug Consumption Value by Application (2026-2031) & (USD Million)
 Table 61. Middle East & Africa Brain Cancer Targeted Drug Consumption Value by Country (2020-2025) & (USD Million)
 Table 62. Middle East & Africa Brain Cancer Targeted Drug Consumption Value by Country (2026-2031) & (USD Million)
 Table 63. Global Key Players of Brain Cancer Targeted Drug Upstream (Raw Materials)
 Table 64. Global Brain Cancer Targeted Drug Typical Customers


List of Figures
 Figure 1. Brain Cancer Targeted Drug Picture
 Figure 2. Global Brain Cancer Targeted Drug Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Figure 3. Global Brain Cancer Targeted Drug Consumption Value Market Share by Type in 2024
 Figure 4. Belzutifan (Welireg)
 Figure 5. Bevacizumab (Avastin)
 Figure 6. Everolimus (Afinitor)
 Figure 7. Global Brain Cancer Targeted Drug Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Figure 8. Brain Cancer Targeted Drug Consumption Value Market Share by Application in 2024
 Figure 9. Hospital Picture
 Figure 10. Retail Pharmacy Picture
 Figure 11. Other Picture
 Figure 12. Global Brain Cancer Targeted Drug Consumption Value, (USD Million): 2020 & 2024 & 2031
 Figure 13. Global Brain Cancer Targeted Drug Consumption Value and Forecast (2020-2031) & (USD Million)
 Figure 14. Global Market Brain Cancer Targeted Drug Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
 Figure 15. Global Brain Cancer Targeted Drug Consumption Value Market Share by Region (2020-2031)
 Figure 16. Global Brain Cancer Targeted Drug Consumption Value Market Share by Region in 2024
 Figure 17. North America Brain Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 18. Europe Brain Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 19. Asia-Pacific Brain Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 20. South America Brain Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 21. Middle East & Africa Brain Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 22. Company Three Recent Developments and Future Plans
 Figure 23. Global Brain Cancer Targeted Drug Revenue Share by Players in 2024
 Figure 24. Brain Cancer Targeted Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
 Figure 25. Market Share of Brain Cancer Targeted Drug by Player Revenue in 2024
 Figure 26. Top 3 Brain Cancer Targeted Drug Players Market Share in 2024
 Figure 27. Top 6 Brain Cancer Targeted Drug Players Market Share in 2024
 Figure 28. Global Brain Cancer Targeted Drug Consumption Value Share by Type (2020-2025)
 Figure 29. Global Brain Cancer Targeted Drug Market Share Forecast by Type (2026-2031)
 Figure 30. Global Brain Cancer Targeted Drug Consumption Value Share by Application (2020-2025)
 Figure 31. Global Brain Cancer Targeted Drug Market Share Forecast by Application (2026-2031)
 Figure 32. North America Brain Cancer Targeted Drug Consumption Value Market Share by Type (2020-2031)
 Figure 33. North America Brain Cancer Targeted Drug Consumption Value Market Share by Application (2020-2031)
 Figure 34. North America Brain Cancer Targeted Drug Consumption Value Market Share by Country (2020-2031)
 Figure 35. United States Brain Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 36. Canada Brain Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 37. Mexico Brain Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 38. Europe Brain Cancer Targeted Drug Consumption Value Market Share by Type (2020-2031)
 Figure 39. Europe Brain Cancer Targeted Drug Consumption Value Market Share by Application (2020-2031)
 Figure 40. Europe Brain Cancer Targeted Drug Consumption Value Market Share by Country (2020-2031)
 Figure 41. Germany Brain Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 42. France Brain Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 43. United Kingdom Brain Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 44. Russia Brain Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 45. Italy Brain Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 46. Asia-Pacific Brain Cancer Targeted Drug Consumption Value Market Share by Type (2020-2031)
 Figure 47. Asia-Pacific Brain Cancer Targeted Drug Consumption Value Market Share by Application (2020-2031)
 Figure 48. Asia-Pacific Brain Cancer Targeted Drug Consumption Value Market Share by Region (2020-2031)
 Figure 49. China Brain Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 50. Japan Brain Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 51. South Korea Brain Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 52. India Brain Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 53. Southeast Asia Brain Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 54. Australia Brain Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 55. South America Brain Cancer Targeted Drug Consumption Value Market Share by Type (2020-2031)
 Figure 56. South America Brain Cancer Targeted Drug Consumption Value Market Share by Application (2020-2031)
 Figure 57. South America Brain Cancer Targeted Drug Consumption Value Market Share by Country (2020-2031)
 Figure 58. Brazil Brain Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 59. Argentina Brain Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 60. Middle East & Africa Brain Cancer Targeted Drug Consumption Value Market Share by Type (2020-2031)
 Figure 61. Middle East & Africa Brain Cancer Targeted Drug Consumption Value Market Share by Application (2020-2031)
 Figure 62. Middle East & Africa Brain Cancer Targeted Drug Consumption Value Market Share by Country (2020-2031)
 Figure 63. Turkey Brain Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 64. Saudi Arabia Brain Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 65. UAE Brain Cancer Targeted Drug Consumption Value (2020-2031) & (USD Million)
 Figure 66. Brain Cancer Targeted Drug Market Drivers
 Figure 67. Brain Cancer Targeted Drug Market Restraints
 Figure 68. Brain Cancer Targeted Drug Market Trends
 Figure 69. Porters Five Forces Analysis
 Figure 70. Brain Cancer Targeted Drug Industrial Chain
 Figure 71. Methodology
 Figure 72. Research Process and Data Source

Companies Mentioned

Merck & Co.
Roche
Novartis